Soleno Therapeutics Files 8-K on Security Holder Vote Matters
Ticker: SLNO · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: SLNO
TL;DR
SOLENO THERAPEUTICS (SLNO) filed an 8-K for a shareholder vote. Details TBD.
AI Summary
On June 5, 2025, Soleno Therapeutics, Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not specify the nature of the vote or any associated details like dates of meetings or specific proposals.
Why It Matters
This filing indicates that Soleno Therapeutics is seeking approval from its shareholders on certain matters, which could impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain information that immediately suggests significant financial or operational risk.
Key Players & Entities
- SOLENO THERAPEUTICS, INC. (company) — Registrant
- June 5, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36593 (identifier) — Commission File Number
- 77-0523891 (identifier) — IRS Employer Identification Number
- 100 Marine Pkwy , Suite 400 Redwood City , CA 94065 (address) — Principal Executive Offices
- 650-213-8444 (phone_number) — Registrant's telephone number
FAQ
What specific matters are being submitted for a vote by Soleno Therapeutics' security holders?
The filing states that matters are being submitted to a vote of security holders, but the specific nature of these matters is not detailed in the provided excerpt.
When is the vote expected to take place?
The filing does not specify the date of the vote or any associated meeting.
Has Soleno Therapeutics provided any preliminary information or recommendations regarding the upcoming vote?
This 8-K filing does not include any preliminary information or recommendations from the company regarding the vote.
What is the significance of filing an 8-K for a submission of matters to a vote?
Filing an 8-K for such matters is a requirement to inform the public and shareholders about significant corporate actions that require shareholder approval.
Does this filing indicate any changes in the company's board of directors or executive management?
The filing pertains to a vote of security holders and does not explicitly mention changes in board or executive management in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).